ArticleKidney international2020
COVID-19 in dialysis patients: outlasting and outsmarting a pandemic.
Article in Kidney international, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 30 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
30 citing papers in PubMed.
- Impact of Providing a Personalized Data Dashboard on Ecological Momentary Assessment Compliance Among College Students Who Use Substances: Pilot Microrandomized Trial.JMIR formative research · 2024Trial
- Differences in COVID-19-related hospitalization burden between kidney transplant recipients and hemodialysis patients vaccinated against COVID-19.Human vaccines & immunotherapeutics · 2026Observational
- Disaster Management in Hemodialysis Centers: Ensuring Continuity of Lifesaving Care.Avicenna journal of medicine · 2026Review
- Severe COVID-19 and chronic kidney disease: bidirectional mendelian randomization study.Virology journal · 2024Article
- Lung ultrasonography performed by nephrologist: COVID-19 as an opportunity to reveal ultrasound's full potential and usefulness in the dialysis room.Clinical kidney journal · 2023Article
- Capacity planning for effective cohorting of hemodialysis patients during the coronavirus pandemic: A case study.European journal of operational research · 2023Article
- Peritoneal catheter insertion: combating barriers through policy change.Clinical kidney journal · 2022Review
- Should More Patients with Kidney Failure Bring Treatment Home? What We Have Learned from COVID-19.Kidney diseases (Basel, Switzerland) · 2022Review
- COVID-19 and Hospitalization Among Maintenance Dialysis Patients: A Retrospective Cohort Study Using Time-Dependent Modeling.Kidney medicine · 2022Article
- Main Barriers to the Introduction of a Home Haemodialysis Programme in Poland: A Review of the Challenges for Implementation and Criteria for a Successful Programme.Journal of clinical medicine · 2022Review
- Depression, anxiety and quality of life of hemodialysis patients before and during the COVID-19 pandemic.Journal of psychosomatic research · 2022Article
- Humoral response to viral vector COVID-19 vaccine in hemodialysis patients.Kidney research and clinical practice · 2022Article
- Efficacy and Safety of Remdesivir in COVID-19 Positive Dialysis Patients.Antibiotics (Basel, Switzerland) · 2022Article
- Severe Acute Respiratory Syndrome Coronavirus 2 Antibody Response After Heterologous Immunizations With ChAdOx1/BNT162b2 in End-Stage Renal Disease Patients on Hemodialysis.Frontiers in immunology · 2022Article
- COVID-19 impact on the renal system: Pathophysiology and clinical outcomes.Best practice & research. Clinical anaesthesiology · 2021Review
- Humoral response after BNT162b2 mRNA COVID-19 vaccination in patients on haemodialysis depends on immune status.Clinical kidney journal · 2021Article
- Acute Kidney Injury and Acute Respiratory Distress Syndrome.Critical care clinics · 2021Review
- Humoral response after 3 doses of the BNT162b2 mRNA COVID-19 vaccine in patients on hemodialysis.Kidney international · 2021Article
- Peritoneal dialysis patients - the forgotten group in the coronavirus pandemic.Clinical medicine (London, England) · 2021Article
- Neutralizing Antibody Responses After SARS-CoV-2 Infection in End-Stage Kidney Disease and Protection Against Reinfection.Kidney international reports · 2021Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
2 authors.
Funding
Abstract
Coronavirus disease 2019 (COVID-19) has affected the care and outcomes of patients treated with dialysis worldwide. In this issue of Kidney International, 3 reports highlight the disproportionately severe impact of COVID-19 on patients on dialysis, noting its high prevalence, particularly among patients receiving in-center dialysis. This likely reflects patients' limited ability to physically distance as well as community exposures, including residence in areas with high rates of infection. Patients on dialysis are at extremely high risk should they develop COVID-19, with short-term mortality of 20% or higher. Accordingly, it is imperative that the kidney community intervenes to reduce the threat of COVID-19 in this vulnerable population by focusing on modifiable factors, including universal masking of patients and staff and enhanced screening, including testing for COVID-19 in the patients who are asymptomatic during times of high local prevalence.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.